LCGC
TWST icon

Legacy Capital Group California’s Twist Bioscience TWST Stock Holding History

Legacy Capital Group California’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,089
Closed -$1.22M – 359
2024
Q3 		$1.22M Buy
27,089
+71
+0.3% +$3.38K 0.41% 50
2024
Q2 		$1.33M Sell
27,018
-1,203
-4% -$49.1K 0.48% 47
2024
Q1 		$968K Buy
+28,221
New +$1.02M 0.36% 75

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Legacy Capital Group California's TWST Position: Q4 2024 in Review

Legacy Capital Group California sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 27,089 shares — an estimated $1.22M sold.

Legacy Capital Group California first reported a position in TWST in Q1 2024 and held it in 3 quarters. The position peaked at $1.33M in Q2 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Legacy Capital Group California reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • Legacy Capital Group California sold 27,089 Twist Bioscience shares in Q4 2024, an estimated $1.22M.
  • Legacy Capital Group California first reported a position in Twist Bioscience in Q1 2024 and held it in 3 quarters.
  • Legacy Capital Group California's Twist Bioscience position peaked at $1.33M in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Legacy Capital Group California's 13F filing for Q4 2024, filed 3 Feb 2025.